222 related articles for article (PubMed ID: 31030674)
1. Subclinical myocardial injury in patients with Facioscapulohumeral muscular dystrophy 1 and preserved ejection fraction - assessment by cardiovascular magnetic resonance.
Blaszczyk E; Grieben U; von Knobelsdorff-Brenkenhoff F; Kellman P; Schmacht L; Funk S; Spuler S; Schulz-Menger J
J Cardiovasc Magn Reson; 2019 Apr; 21(1):25. PubMed ID: 31030674
[TBL] [Abstract][Full Text] [Related]
2. Progressive myocardial injury in myotonic dystrophy type II and facioscapulohumeral muscular dystrophy 1: a cardiovascular magnetic resonance follow-up study.
Blaszczyk E; Lim C; Kellman P; Schmacht L; Gröschel J; Spuler S; Schulz-Menger J
J Cardiovasc Magn Reson; 2021 Nov; 23(1):130. PubMed ID: 34743704
[TBL] [Abstract][Full Text] [Related]
3. Cardiac Involvement in Myotonic Dystrophy Type 2 Patients With Preserved Ejection Fraction: Detection by Cardiovascular Magnetic Resonance.
Schmacht L; Traber J; Grieben U; Utz W; Dieringer MA; Kellman P; Blaszczyk E; von Knobelsdorff-Brenkenhoff F; Spuler S; Schulz-Menger J
Circ Cardiovasc Imaging; 2016 Jul; 9(7):. PubMed ID: 27363857
[TBL] [Abstract][Full Text] [Related]
4. T
Maforo NG; Magrath P; Moulin K; Shao J; Kim GH; Prosper A; Renella P; Wu HH; Halnon N; Ennis DB
J Cardiovasc Magn Reson; 2020 Dec; 22(1):85. PubMed ID: 33302967
[TBL] [Abstract][Full Text] [Related]
5. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
[TBL] [Abstract][Full Text] [Related]
6. T1 and T2 mapping for evaluation of myocardial involvement in patients with ANCA-associated vasculitides.
Greulich S; Mayr A; Kitterer D; Latus J; Henes J; Steubing H; Kaesemann P; Patrascu A; Greiser A; Groeninger S; Braun N; Alscher MD; Sechtem U; Mahrholdt H
J Cardiovasc Magn Reson; 2017 Jan; 19(1):6. PubMed ID: 28077133
[TBL] [Abstract][Full Text] [Related]
7. Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis--a clinical study using myocardial T1-mapping and extracellular volume quantification.
Ntusi NA; Piechnik SK; Francis JM; Ferreira VM; Rai AB; Matthews PM; Robson MD; Moon J; Wordsworth PB; Neubauer S; Karamitsos TD
J Cardiovasc Magn Reson; 2014 Mar; 16(1):21. PubMed ID: 24593856
[TBL] [Abstract][Full Text] [Related]
8. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular magnetic resonance of cardiomyopathy in limb girdle muscular dystrophy 2B and 2I.
Rosales XQ; Moser SJ; Tran T; McCarthy B; Dunn N; Habib P; Simonetti OP; Mendell JR; Raman SV
J Cardiovasc Magn Reson; 2011 Aug; 13(1):39. PubMed ID: 21816046
[TBL] [Abstract][Full Text] [Related]
10. Pattern and prognostic value of cardiac involvement in patients with late-onset pompe disease: a comprehensive cardiovascular magnetic resonance approach.
Boentert M; Florian A; Dräger B; Young P; Yilmaz A
J Cardiovasc Magn Reson; 2016 Dec; 18(1):91. PubMed ID: 27931223
[TBL] [Abstract][Full Text] [Related]
11. Myocardial fibrosis by late gadolinium enhancement cardiovascular magnetic resonance in myotonic muscular dystrophy type 1: highly prevalent but not associated with surface conduction abnormality.
Cardona A; Arnold WD; Kissel JT; Raman SV; Zareba KM
J Cardiovasc Magn Reson; 2019 May; 21(1):26. PubMed ID: 31046780
[TBL] [Abstract][Full Text] [Related]
12. Diffuse myocardial fibrosis in patients with mitral valve prolapse and ventricular arrhythmia.
Bui AH; Roujol S; Foppa M; Kissinger KV; Goddu B; Hauser TH; Zimetbaum PJ; Ngo LH; Manning WJ; Nezafat R; Delling FN
Heart; 2017 Feb; 103(3):204-209. PubMed ID: 27515954
[TBL] [Abstract][Full Text] [Related]
13. Variations in native T1 values in patients with Duchenne muscular dystrophy with and without late gadolinium enhancement.
Lang SM; Alsaied T; Khoury PR; Ryan TD; Taylor MD
Int J Cardiovasc Imaging; 2021 Feb; 37(2):635-642. PubMed ID: 32951096
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of myocardial involvement in patients with connective tissue disorders: a multi-parametric cardiovascular magnetic resonance study.
Mayr A; Kitterer D; Latus J; Steubing H; Henes J; Vecchio F; Kaesemann P; Patrascu A; Greiser A; Groeninger S; Braun N; Alscher MD; Sechtem U; Mahrholdt H; Greulich S
J Cardiovasc Magn Reson; 2016 Oct; 18(1):67. PubMed ID: 27733210
[TBL] [Abstract][Full Text] [Related]
15. Cardiac magnetic resonance imaging for the detection of myocardial involvement in granulomatosis with polyangiitis.
Giollo A; Dumitru RB; Swoboda PP; Plein S; Greenwood JP; Buch MH; Andrews J
Int J Cardiovasc Imaging; 2021 Mar; 37(3):1053-1062. PubMed ID: 33057879
[TBL] [Abstract][Full Text] [Related]
16. Non-contrast cardiovascular magnetic resonance detection of myocardial fibrosis in Duchenne muscular dystrophy.
Raucci FJ; Xu M; George-Durrett K; Crum K; Slaughter JC; Parra DA; Markham LW; Soslow JH
J Cardiovasc Magn Reson; 2021 Apr; 23(1):48. PubMed ID: 33910579
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive cardiac magnetic resonance T1, T2, and extracellular volume mapping to define Duchenne cardiomyopathy.
Sunthankar SD; George-Durrett K; Crum K; Slaughter JC; Kasten J; Raucci FJ; Markham LW; Soslow JH
J Cardiovasc Magn Reson; 2023 Jul; 25(1):44. PubMed ID: 37517994
[TBL] [Abstract][Full Text] [Related]
18. Myocardial injury in patients with acute ischemic stroke detected by cardiovascular magnetic resonance imaging.
Blaszczyk E; Hellwig S; Saad H; Ganeshan R; Stengl H; Nolte CH; Fiebach JB; Endres M; Kuhnt J; Gröschel J; Schulz-Menger J; Scheitz JF
Eur J Radiol; 2023 Aug; 165():110908. PubMed ID: 37315403
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis.
Lin L; Li X; Feng J; Shen KN; Tian Z; Sun J; Mao YY; Cao J; Jin ZY; Li J; Selvanayagam JB; Wang YN
J Cardiovasc Magn Reson; 2018 Jan; 20(1):2. PubMed ID: 29298704
[TBL] [Abstract][Full Text] [Related]
20. Acute impact of an endurance race on cardiac function and biomarkers of myocardial injury in triathletes with and without myocardial fibrosis.
Tahir E; Scherz B; Starekova J; Muellerleile K; Fischer R; Schoennagel B; Warncke M; Stehning C; Cavus E; Bohnen S; Radunski UK; Blankenberg S; Simon P; Pressler A; Adam G; Patten M; Lund GK
Eur J Prev Cardiol; 2020 Jan; 27(1):94-104. PubMed ID: 31242053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
